Roche reports positive data from SMA treatment trial
Roche has reported positive data from the dose finding Part I FIREFISH study of Evrysdi (risdiplam) in infants with symptomatic…
Latest News
-
9 hours
-
13 hours
-
14 hours
-
1 day
-
9 hours
-
13 hours
-
14 hours
-
1 day
Constant Therapeutics’ drug enters Phase II trial for Covid-19 in Israel
Israel’s Rambam Medical Health Care Campus and Ziv Medical Center researchers have begun a Phase II clinical trial of Constant…
Latest News
View More
Stealth BioTherapeutics concludes enrolment in Phase II AMD study
Stealth BioTherapeutics has completed enrolment in the Phase II ReCLAIM-2 study (SPIAM-202) of its lead product candidate, elamipretide, in patients with dry age-related macular degeneration…
NeuroRx’s Zyesami accelerates recovery in Covid-19 trial
NeuroRx has reported that the Phase IIb/III trial of Zyesami (aviptadil, previously RLF-100) showed multidimensional benefit in treating respiratory failure in critically ill Covid-19 patients.…
Yale announces new trial to reduce Covid-19 complications with new therapy combo
Yale School of Medicine has announced a randomised clinical trial led by the Yale Cardiovascular Research Group (YCRG) to study…
RedHill Biopharma to expand Covid-19 trial of opaganib to US
Specialty biopharmaceutical company RedHill Biopharma is set to expand its global Phase II/III study of opaganib in patients with severe…
Adamis to commence Phase II/III study of Covid-19 therapy
Speciality biopharmaceutical company Adamis Pharmaceuticals is set to proceed with the Phase II/III study of Tempol (MBM-02) for treating Covid-19.…
Amyris reports positive pre-clinical data for Covid-19 RNA vaccine platform
Biotechnology company Amyris has reported positive preliminary results in a pre-clinical study of its ribonucleic acid (RNA) vaccine platform for…
Company A-Z
View More
VaLea Clinical Trials
Patient-Centric Services for In-Home or Alternate-Site Clinical Trials Settings
Latest Content
View More
NovalGen and HALIX enter clinical trial materials manufacturing partnership
Biopharmaceutical company NovalGen has entered a strategic partnership with contract development and manufacturing organisation HALIX to manufacture clinical trial materials.…
Perception’s PCN-101 safe and well-tolerated in Phase I clinical study
Perception Neuroscience has reported positive data from its first Phase 1 clinical study of PCN-101 (R-ketamine) in healthy adult participants.…
UKONIQ™ (umbralisib) for the Treatment of Marginal Zone Lymphoma (MZL) and Follicular Lymphoma (FL)
UKONIQ™ (umbralisib) is the first and only oral, dual inhibitor of phosphoinositide 3 kinase (PI3K) delta and casein kinase 1…
New Warehouse Construction at Staufen Headquarters
In the past few months, two new warehouses were erected and put into operation on the IKA premises. IKA continues…
The Complete Guide to Freelancers in MedTech
The global MedTech outsourcing market has ballooned as businesses look for ways to improve patient care while streamlining their own…